vs

Side-by-side financial comparison of Clene Inc. (CLNN) and Cyngn Inc. (CYN). Click either name above to swap in a different company.

Clene Inc. is the larger business by last-quarter revenue ($77.0K vs $68.1K, roughly 1.1× Cyngn Inc.). On growth, Clene Inc. posted the faster year-over-year revenue change (-15.4% vs -77.8%). Clene Inc. produced more free cash flow last quarter ($-4.8M vs $-24.8M). Over the past eight quarters, Cyngn Inc.'s revenue compounded faster (251.5% CAGR vs 2.7%).

Clene Inc. is a clinical-stage biopharmaceutical company that develops novel neuroprotective therapeutics to treat neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), multiple sclerosis, and Parkinson’s disease. It operates primarily in the U.S. market, focusing on advancing its small molecule candidate pipeline through clinical trials to address unmet medical needs.

Cyngn Inc. is a technology firm specializing in AI-powered autonomous driving solutions for industrial use cases. It develops self-driving software and hardware integration tools for industrial vehicles including forklifts and pallet trucks, serving manufacturing, warehousing, and logistics customers across North America to improve operational efficiency and worksite safety.

CLNN vs CYN — Head-to-Head

Bigger by revenue
CLNN
CLNN
1.1× larger
CLNN
$77.0K
$68.1K
CYN
Growing faster (revenue YoY)
CLNN
CLNN
+62.4% gap
CLNN
-15.4%
-77.8%
CYN
More free cash flow
CLNN
CLNN
$20.0M more FCF
CLNN
$-4.8M
$-24.8M
CYN
Faster 2-yr revenue CAGR
CYN
CYN
Annualised
CYN
251.5%
2.7%
CLNN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CLNN
CLNN
CYN
CYN
Revenue
$77.0K
$68.1K
Net Profit
$-9.2M
Gross Margin
70.1%
17.5%
Operating Margin
-9733.8%
Net Margin
-11981.8%
Revenue YoY
-15.4%
-77.8%
Net Profit YoY
31.9%
87.7%
EPS (diluted)

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLNN
CLNN
CYN
CYN
Q4 25
$77.0K
$68.1K
Q3 25
$15.0K
$70.0K
Q2 25
$27.0K
$33.7K
Q1 25
$81.0K
$47.2K
Q4 24
$91.0K
$306.4K
Q3 24
$87.0K
$47.6K
Q2 24
$91.0K
$8.7K
Q1 24
$73.0K
$5.5K
Net Profit
CLNN
CLNN
CYN
CYN
Q4 25
$-9.2M
Q3 25
$-8.8M
$-8.4M
Q2 25
$-7.4M
$-5.4M
Q1 25
$-751.0K
$-7.6M
Q4 24
$-13.5M
$-16.1M
Q3 24
$-8.0M
$-5.4M
Q2 24
$-6.8M
$-5.8M
Q1 24
$-11.1M
$-6.0M
Gross Margin
CLNN
CLNN
CYN
CYN
Q4 25
70.1%
17.5%
Q3 25
27.4%
Q2 25
49.8%
Q1 25
75.3%
74.9%
Q4 24
80.2%
18.5%
Q3 24
79.3%
Q2 24
80.2%
Q1 24
78.1%
Operating Margin
CLNN
CLNN
CYN
CYN
Q4 25
-9733.8%
Q3 25
-37653.3%
-12028.9%
Q2 25
-21718.5%
-16313.4%
Q1 25
-5032.1%
-11060.0%
Q4 24
-9511.0%
-1808.7%
Q3 24
-8982.8%
-11575.7%
Q2 24
-8122.0%
-67076.8%
Q1 24
-12646.6%
-108223.5%
Net Margin
CLNN
CLNN
CYN
CYN
Q4 25
-11981.8%
Q3 25
-58513.3%
-12059.9%
Q2 25
-27477.8%
-16154.6%
Q1 25
-927.2%
-16102.9%
Q4 24
-14889.0%
-5261.2%
Q3 24
-9179.3%
-11405.9%
Q2 24
-7456.0%
-67154.7%
Q1 24
-15178.1%
-108290.9%
EPS (diluted)
CLNN
CLNN
CYN
CYN
Q4 25
Q3 25
$-1.20
Q2 25
$-2.70
Q1 25
$-6.60
Q4 24
$-1079.39
Q3 24
$-408.30
Q2 24
$-610.85
Q1 24
$-422.87

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLNN
CLNN
CYN
CYN
Cash + ST InvestmentsLiquidity on hand
$5.2M
$34.7M
Total DebtLower is stronger
$17.8M
Stockholders' EquityBook value
$-17.6M
$38.8M
Total Assets
$18.1M
$50.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLNN
CLNN
CYN
CYN
Q4 25
$5.2M
$34.7M
Q3 25
$7.9M
$34.9M
Q2 25
$7.3M
$39.2M
Q1 25
$9.8M
$16.3M
Q4 24
$12.2M
$23.6M
Q3 24
$14.6M
$812.8K
Q2 24
$21.7M
$7.0M
Q1 24
$27.9M
$4.8M
Total Debt
CLNN
CLNN
CYN
CYN
Q4 25
$17.8M
Q3 25
$17.9M
Q2 25
$16.5M
Q1 25
$16.6M
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
CLNN
CLNN
CYN
CYN
Q4 25
$-17.6M
$38.8M
Q3 25
$-12.4M
$38.7M
Q2 25
$-8.6M
$46.8M
Q1 25
$-5.0M
$22.1M
Q4 24
$-8.9M
$-1.0M
Q3 24
$-4.1M
$6.6M
Q2 24
$-504.0K
$9.7M
Q1 24
$4.3M
$8.0M
Total Assets
CLNN
CLNN
CYN
CYN
Q4 25
$18.1M
$50.1M
Q3 25
$22.3M
$49.3M
Q2 25
$22.1M
$56.2M
Q1 25
$25.3M
$24.3M
Q4 24
$27.3M
$30.1M
Q3 24
$31.6M
$8.5M
Q2 24
$40.3M
$11.9M
Q1 24
$45.1M
$9.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLNN
CLNN
CYN
CYN
Operating Cash FlowLast quarter
$-4.8M
$-23.6M
Free Cash FlowOCF − Capex
$-4.8M
$-24.8M
FCF MarginFCF / Revenue
-6268.8%
-36414.2%
Capex IntensityCapex / Revenue
36.4%
1806.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-42.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLNN
CLNN
CYN
CYN
Q4 25
$-4.8M
$-23.6M
Q3 25
$-4.0M
$-4.1M
Q2 25
$-4.7M
$-6.3M
Q1 25
$-5.0M
$-6.5M
Q4 24
$-4.9M
$-3.6M
Q3 24
$-3.0M
$-5.3M
Q2 24
$-6.4M
$-4.4M
Q1 24
$-7.1M
$-5.8M
Free Cash Flow
CLNN
CLNN
CYN
CYN
Q4 25
$-4.8M
$-24.8M
Q3 25
$-4.0M
$-4.6M
Q2 25
$-6.4M
Q1 25
$-6.7M
Q4 24
$-4.9M
$-4.0M
Q3 24
$-3.0M
$-5.5M
Q2 24
$-6.4M
$-4.7M
Q1 24
$-7.1M
$-6.1M
FCF Margin
CLNN
CLNN
CYN
CYN
Q4 25
-6268.8%
-36414.2%
Q3 25
-26686.7%
-6552.1%
Q2 25
-19070.4%
Q1 25
-14191.4%
Q4 24
-5347.3%
-1291.7%
Q3 24
-3475.9%
-11531.2%
Q2 24
-6986.8%
-54799.1%
Q1 24
-9716.4%
-109824.6%
Capex Intensity
CLNN
CLNN
CYN
CYN
Q4 25
36.4%
1806.3%
Q3 25
73.3%
742.5%
Q2 25
0.0%
517.1%
Q1 25
0.0%
378.5%
Q4 24
1.1%
101.7%
Q3 24
1.1%
341.4%
Q2 24
2.2%
4192.3%
Q1 24
15.1%
3886.1%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons